Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mike Sharland

Showing results (41-50 of 285) with videos related to

Pageof 29
Sort By:
International Journal of Antimicrobial Agents|February 9, 2011
Ganciclovir treatment in children: evidence of subtherapeutic levelsSuzanne Luck, Andrew Lovering, Paul Griffiths, et al.
Current Opinion in Infectious Diseases|April 9, 2010
Risk-benefit analysis of restricting antimicrobial prescribing in children: what do we really know?Tamara Keith, Sonia Saxena, Joanna Murray, et al.
Pediatric Research|August 24, 2002
Steroids fail to down-regulate respiratory syncytial virus-induced IL-8 secretion in infantsLynette H Thomas, Mike Sharland, Jon S Friedland
Journal of the Pediatric Infectious Diseases Society|March 25, 2017
High Reported Rates of Antimicrobial Resistance in Indian Neonatal and Pediatric Blood Stream InfectionsDhanya Dharmapalan, Anita Shet, Vijay Yewale, et al.
Archives of Disease in Childhood. Fetal and Neonatal Edition|November 2, 2010
Improving antibiotic prescribing in neonatal units: time to actAlison Bedford Russell, Mike Sharland, Paul T Heath
Annals of Family Medicine|May 13, 2015
Impact of UK Primary Care Policy Reforms on Short-Stay Unplanned Hospital Admissions for Children With Primary Care-Sensitive ConditionsElizabeth Cecil, Alex Bottle, Mike Sharland, et al.
The Pediatric Infectious Disease Journal|July 26, 2016
Preemptive Screening Strategies to Identify Postnatal CMV Diseases on the Neonatal UnitSeilesh Kadambari, Suzanne Luck, Paul T Heath, et al.
The Pediatric Infectious Disease Journal|July 2, 2019
Strategic Trials to Define the Best Available Treatment for Neonatal and Pediatric Sepsis Caused by Carbapenem-resistant OrganismsDaniele Donà, Mike Sharland, Paul T Heath, et al.
The Pediatric Infectious Disease Journal|December 16, 2016
Intensive Care Admissions for Children With Enterovirus and Human Parechovirus Infections in the United Kingdom and The Republic of Ireland, 2010-2014Serena Braccio, Melpo Kapetanstrataki, Mike Sharland, et al.
BMJ Case Reports|January 29, 2013
Rifampicin pharmacokinetics in extreme prematurity to treat congenital tuberculosisKirsty Le Doare, Nathaniel Barber, Katja Doerholt, et al.
Pageof 29

Showing results (41-50 of 285) with videos related to

Sort By:
Pageof 29
International Journal of Antimicrobial Agents|February 9, 2011
Ganciclovir treatment in children: evidence of subtherapeutic levelsSuzanne Luck, Andrew Lovering, Paul Griffiths, et al.
Current Opinion in Infectious Diseases|April 9, 2010
Risk-benefit analysis of restricting antimicrobial prescribing in children: what do we really know?Tamara Keith, Sonia Saxena, Joanna Murray, et al.
Pediatric Research|August 24, 2002
Steroids fail to down-regulate respiratory syncytial virus-induced IL-8 secretion in infantsLynette H Thomas, Mike Sharland, Jon S Friedland
Journal of the Pediatric Infectious Diseases Society|March 25, 2017
High Reported Rates of Antimicrobial Resistance in Indian Neonatal and Pediatric Blood Stream InfectionsDhanya Dharmapalan, Anita Shet, Vijay Yewale, et al.
Archives of Disease in Childhood. Fetal and Neonatal Edition|November 2, 2010
Improving antibiotic prescribing in neonatal units: time to actAlison Bedford Russell, Mike Sharland, Paul T Heath
Annals of Family Medicine|May 13, 2015
Impact of UK Primary Care Policy Reforms on Short-Stay Unplanned Hospital Admissions for Children With Primary Care-Sensitive ConditionsElizabeth Cecil, Alex Bottle, Mike Sharland, et al.
The Pediatric Infectious Disease Journal|July 26, 2016
Preemptive Screening Strategies to Identify Postnatal CMV Diseases on the Neonatal UnitSeilesh Kadambari, Suzanne Luck, Paul T Heath, et al.
The Pediatric Infectious Disease Journal|July 2, 2019
Strategic Trials to Define the Best Available Treatment for Neonatal and Pediatric Sepsis Caused by Carbapenem-resistant OrganismsDaniele Donà, Mike Sharland, Paul T Heath, et al.
The Pediatric Infectious Disease Journal|December 16, 2016
Intensive Care Admissions for Children With Enterovirus and Human Parechovirus Infections in the United Kingdom and The Republic of Ireland, 2010-2014Serena Braccio, Melpo Kapetanstrataki, Mike Sharland, et al.
BMJ Case Reports|January 29, 2013
Rifampicin pharmacokinetics in extreme prematurity to treat congenital tuberculosisKirsty Le Doare, Nathaniel Barber, Katja Doerholt, et al.
Pageof 29